Skip to main content

Table 3 Hazard ratios for overall survival

From: Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia

 

BAL lymphocytes

 ≤ 15% (n = 107)

 > 15% (n = 79)

Anti-inflammatory drugs

 Yes (n = 123)

1.00

0.26 (0.11–0.63)

 No (n = 63)

0.43 (0.17–1.08)

0.80 (0.29–2.18)

  1. BAL bronchoalveolar lavage